Influence of an  -amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading tests in rats, dogs and man.
D000328:Adult; D000681:Amylases / Q000037:antagonists & inhibitors*; D000818:Animals; D001381:Azepines / Q000008:administration & dosage; D001786:Blood Glucose / Q000378:metabolism; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D006868:Hydrolysis; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000097:blood; D008297:Male; D010080:Oxazoles / Q000008:administration & dosage; D051381:Rats; D013213:Starch / Q000378:metabolism*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage; D014908:Triticum
D001381:Azepines; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D010080:Oxazoles; D013453:Sulfonylurea Compounds; D013213:Starch; D000681:Amylases